advertisement
Aihara M 20
Showing records 1 to 20 | Display all abstracts from Aihara M72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Aoyama-Araki Y
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Aihara M
Acta Ophthalmologica 2017; 95: e720-e726
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Komae K
Journal of Glaucoma 2017; 26: 603-607
72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Honjo M
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Takamoto M
Journal of Glaucoma 2017; 26: 603-607
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Adachi M
Acta Ophthalmologica 2017; 95: e720-e726
72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Uchida T
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Tanaka R
Journal of Glaucoma 2017; 26: 603-607
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Matsuo H
Acta Ophthalmologica 2017; 95: e720-e726
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Aihara M
Journal of Glaucoma 2017; 26: 603-607
72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Yamagishi R
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Togano T
Acta Ophthalmologica 2017; 95: e720-e726
72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Kano K
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Ohtomo K
Journal of Glaucoma 2017; 26: 603-607
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Fukuchi T; Sasaki N
Acta Ophthalmologica 2017; 95: e720-e726
72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Aoki J
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Okinaga K
Journal of Glaucoma 2017; 26: 603-607
72774 Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients
Acta Ophthalmologica 2017; 95: e720-e726
72871 Sphingosine-1-Phosphate (S1P)-Related Response of Human Conjunctival Fibroblasts After Filtration Surgery for Glaucoma
Aihara M
Investigative Ophthalmology and Visual Science 2017; 58: 2258-2265
72767 Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Behçet Disease Patients
Matsuda J; Nakahara H; Fujino Y; Kaburaki T
Journal of Glaucoma 2017; 26: 603-607